mHealth Interventions to Improve Cancer Screening and Early Detection: Scoping Review of Reviews.
cancer
cancer detection
cancer screening
digital health
mHealth
mobile health
mobile phone
oncology
review
scoping review
scoping review of reviews
Journal
Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882
Informations de publication
Date de publication:
15 08 2022
15 08 2022
Historique:
received:
13
01
2022
accepted:
16
06
2022
revised:
14
06
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
18
8
2022
Statut:
epublish
Résumé
Cancer screening provision in resource-constrained settings tends to be opportunistic, and uptake tends to be low, leading to delayed presentation and treatment and poor survival. The aim of this study was to identify, review, map, and summarize findings from different types of literature reviews on the use of mobile health (mHealth) technologies to improve the uptake of cancer screening. The review methodology was guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Ovid MEDLINE, PyscINFO, and Embase were searched from inception to May 2021. The eligible criteria included reviews that focused on studies of interventions that used mobile phone devices to promote and deliver cancer screening and described the effectiveness or implementation of mHealth intervention outcomes. Key data fields such as study aims, types of cancer, mHealth formats, and outcomes were extracted, and the data were analyzed to address the objective of the review. Our initial search identified 1981 titles, of which 12 (0.61%) reviews met the inclusion criteria (systematic reviews: n=6, 50%; scoping reviews: n=4, 33%; rapid reviews: n=1, 8%; narrative reviews: n=1, 8%). Most (57/67, 85%) of the interventions targeted breast and cervical cancer awareness and screening uptake. The most commonly used mHealth technologies for increasing cancer screening uptake were SMS text messages and telephone calls. Overall, mHealth interventions increased knowledge about screening and had high acceptance among participants. The likelihood of achieving improved uptake-related outcomes increased when interventions used >1 mode of communication (telephone reminders, physical invitation letters, and educational pamphlets) together with mHealth. mHealth interventions increase cancer screening uptake, although multiple modes used in combination seem to be more effective.
Sections du résumé
BACKGROUND
Cancer screening provision in resource-constrained settings tends to be opportunistic, and uptake tends to be low, leading to delayed presentation and treatment and poor survival.
OBJECTIVE
The aim of this study was to identify, review, map, and summarize findings from different types of literature reviews on the use of mobile health (mHealth) technologies to improve the uptake of cancer screening.
METHODS
The review methodology was guided by the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews). Ovid MEDLINE, PyscINFO, and Embase were searched from inception to May 2021. The eligible criteria included reviews that focused on studies of interventions that used mobile phone devices to promote and deliver cancer screening and described the effectiveness or implementation of mHealth intervention outcomes. Key data fields such as study aims, types of cancer, mHealth formats, and outcomes were extracted, and the data were analyzed to address the objective of the review.
RESULTS
Our initial search identified 1981 titles, of which 12 (0.61%) reviews met the inclusion criteria (systematic reviews: n=6, 50%; scoping reviews: n=4, 33%; rapid reviews: n=1, 8%; narrative reviews: n=1, 8%). Most (57/67, 85%) of the interventions targeted breast and cervical cancer awareness and screening uptake. The most commonly used mHealth technologies for increasing cancer screening uptake were SMS text messages and telephone calls. Overall, mHealth interventions increased knowledge about screening and had high acceptance among participants. The likelihood of achieving improved uptake-related outcomes increased when interventions used >1 mode of communication (telephone reminders, physical invitation letters, and educational pamphlets) together with mHealth.
CONCLUSIONS
mHealth interventions increase cancer screening uptake, although multiple modes used in combination seem to be more effective.
Identifiants
pubmed: 35969450
pii: v24i8e36316
doi: 10.2196/36316
pmc: PMC9425170
doi:
Types de publication
Journal Article
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e36316Subventions
Organisme : Medical Research Council
ID : MR/K023241/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V005901/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S014349/1
Pays : United Kingdom
Informations de copyright
©Désirée Schliemann, Min Min Tan, Wilfred Mok Kok Hoe, Devi Mohan, Nur Aishah Taib, Michael Donnelly, Tin Tin Su. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 15.08.2022.
Références
Int J Cancer. 2014 May 1;134(9):2223-30
pubmed: 24127304
JCO Glob Oncol. 2020 Apr;6:617-627
pubmed: 32302236
Lancet Oncol. 2010 Aug;11(8):725-32
pubmed: 20598634
Radiol Bras. 2016 Sep-Oct;49(5):305-310
pubmed: 27818544
Asian Pac J Cancer Prev. ;18(8):2221-2226
pubmed: 28843259
Med J Malaysia. 2018 Aug;73(4):202-211
pubmed: 30121682
Glob Health Sci Pract. 2013 Aug 06;1(2):160-71
pubmed: 25276529
JAMA Intern Med. 2014 Aug;174(8):1235-41
pubmed: 24934845
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Rural Health. 2009 Fall;25(4):366-71
pubmed: 19780916
Breast Cancer (Dove Med Press). 2018 Jul 12;10:113-119
pubmed: 30034251
Prev Med. 2019 Jun;123:250-261
pubmed: 30936001
PLoS One. 2018 Feb 1;13(2):e0191764
pubmed: 29389972
JMIR Mhealth Uhealth. 2018 Apr 30;6(4):e104
pubmed: 29712622
JMIR Mhealth Uhealth. 2017 Nov 07;5(11):e154
pubmed: 29113961
Cochrane Database Syst Rev. 2013 Jun 04;(6):CD001877
pubmed: 23737396
PLoS One. 2017 Sep 5;12(9):e0183924
pubmed: 28873092
J Med Internet Res. 2014 Aug 27;16(8):e196
pubmed: 25164545
Prev Med. 2021 Feb;143:106387
pubmed: 33383069
Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):17
pubmed: 29508084
J Med Internet Res. 2020 Nov 9;22(11):e21582
pubmed: 33164907
J Health Commun. 2018;23(9):842-853
pubmed: 30300091
AMIA Annu Symp Proc. 2011;2011:732-41
pubmed: 22195130
Lancet Oncol. 2010 Feb;11(2):165-73
pubmed: 20005175
Eur J Cancer. 2020 Oct;138:232-233
pubmed: 32811688
Eur J Public Health. 2014 Apr;24(2):264-70
pubmed: 23813710
Cancer Epidemiol. 2021 Oct;74:101995
pubmed: 34416545
JMIR Mhealth Uhealth. 2019 Feb 11;7(2):e10930
pubmed: 30741644
BMC Cancer. 2020 Mar 25;20(1):252
pubmed: 32213173
BMJ Glob Health. 2020 May;5(5):
pubmed: 32409331
J Cardiovasc Transl Res. 2014 Nov;7(8):677-91
pubmed: 25209729
World J Gastroenterol. 2017 May 28;23(20):3632-3642
pubmed: 28611516
JMIR Mhealth Uhealth. 2018 Jan 17;6(1):e23
pubmed: 29343463
Gastrointest Endosc. 2012 Jul;76(1):126-35
pubmed: 22726471
Health Educ Behav. 2015 Jun;42(3):352-60
pubmed: 25512072
JMIR Form Res. 2019 Aug 06;3(3):e12675
pubmed: 31389334
JMIR Mhealth Uhealth. 2018 Nov 20;6(11):e196
pubmed: 30459141
Crit Rev Oncol Hematol. 2021 Jan;157:103123
pubmed: 33190065
Mil Med. 2001 Apr;166(4):347-9
pubmed: 11315478
JCO Clin Cancer Inform. 2018 Dec;2:1-11
pubmed: 30652617
Public Health Nurs. 2019 Mar;36(2):164-171
pubmed: 30370687
J Womens Health (Larchmt). 2015 Dec;24(12):1013-20
pubmed: 26360918
BMC Cancer. 2021 Oct 19;21(1):1125
pubmed: 34666704
JMIR Mhealth Uhealth. 2018 Aug 02;6(8):e164
pubmed: 30072362
Rev Lat Am Enfermagem. 2017 Feb 06;25:e2844
pubmed: 28177055
BMC Public Health. 2020 May 11;20(1):654
pubmed: 32393218
J Med Internet Res. 2012 Jan 12;14(1):e3
pubmed: 22262730
Front Public Health. 2019 Nov 06;7:298
pubmed: 31781525
Asian Pac J Cancer Prev. 2009 Apr-Jun;10(2):319-22
pubmed: 19537904
Gesundheitswesen. 2012 Feb;74(2):61-70
pubmed: 21229475
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
J Clin Oncol. 2014 Mar 20;32(9):942-8
pubmed: 24516014
Healthc Inform Res. 2013 Dec;19(4):250-60
pubmed: 24523989
J Health Psychol. 2017 Sep;22(11):1365-1375
pubmed: 26888327
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32522738
Prev Med. 2011 Oct;53(4-5):325-7
pubmed: 21871480
BMJ Innov. 2019 Jan;5(1):28-34
pubmed: 31645991
Psychooncology. 2017 Sep;26(9):1239-1253
pubmed: 28665554
Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e007031
pubmed: 32885681
J Cancer Surviv. 2019 Feb;13(1):97-107
pubmed: 30635865
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
J Med Screen. 2017 Sep;24(3):127-145
pubmed: 27754937
Oncologist. 2014 Feb;19(2):177-85
pubmed: 24396050
J Med Internet Res. 2017 Aug 24;19(8):e296
pubmed: 28838885
Health Policy Technol. 2022 Mar;11(1):100595
pubmed: 35018280
Contemp Clin Trials Commun. 2019 Mar 17;14:100349
pubmed: 31049460
BMJ Open. 2020 Aug 20;10(8):e036503
pubmed: 32819988